Navigation Links
AMRI Date and Time Change for J.P. Morgan Healthcare Conference Presentation
Date:1/10/2016

ALBANY, N.Y., Jan. 10, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2016 at 8:00 a.m. PT, with a question and answer session to follow at 8:30 a.m. PT. A live audio webcast of the presentation and question and answer session can be accessed at AMRI's Investor Relations web site at http://ir.amriglobal.com/events.cfm?CalendarID=2           

The webcast will be archived for 90 days following the live presentation.

About AMRI

Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Solutions (DDS), Active Pharmaceutical Ingredients (API), and Drug Product Manufacturing (DPM). Our DDS segment provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. API supports the chemical development and cGMP manufacture of complex API, including potent, controlled substances, biologics, peptides, steroids, hormones, cytotoxic compounds and sterile API. DPM supports development through commercial scale production of complex liquid-filled and lyophilized parenterals, sterile suspensions and ophthalmic formulations. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).


'/>"/>
SOURCE AMRI
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
2. CVSL Inc. Name Change Becomes Official
3. ReproCELL Inc. Announces Approval for Listing on the Osaka Stock Exchange JASDAQ Market Growth
4. TNI BioTech, Inc. Announces Mandatory Exchange of Common Stock Certificates CUSIP Number 872608104 for New Stock Certificates with Active CUSIP 872608203
5. CVBT Shareholders Vote for Change
6. W.K. Kellogg Foundation announces Mission Driven Investment in SeeChange Health
7. Gerard Design Changes Its Name to Reflect Its Services and Expertise
8. HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)
9. Anthera Pharmaceuticals Announces Personnel Changes
10. One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs
11. Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... ... December 05, 2018 , ... ... The BFE meeting is an interdisciplinary biofeedback conference to nurture communication and education ... education and other disciplines come together to share and learn. The meeting offers ...
(Date:11/29/2018)... ... 29, 2018 , ... Cantata Health, a leading provider of ... care, post-acute care, and long-term care facilities, announced today Elvira Hynds, RHIT has ... Cantata Health’s highly regarded customer support team focusing on initiatives to continuously improve ...
(Date:11/28/2018)... (PRWEB) , ... November 28, 2018 , ... ... provider, is pleased to announce a new partnership with CME Master, a division ... the Middle East, with expansion into South East Asia expected soon. This new ...
Breaking Medicine Technology:
(Date:12/10/2018)... ... December 10, 2018 , ... Five years ago, Erica Lester was diagnosed with clinical ... man who loved me to pieces. I had two beautiful daughters. I had a great ... miserable.” , Lester says she spent most days struggling to get out of bed. ...
(Date:12/8/2018)... WASHINGTON (PRWEB) , ... December 07, 2018 , ... ... nomination. , At this critical juncture in world affairs, U.S. leadership and funding ... U.S.-UN relationship over the years—great strides in reducing extreme poverty and advancing global ...
(Date:12/6/2018)... Fla. (PRWEB) , ... December 06, 2018 , ... ... unable to cope with day-to-day life, there are alternative solutions. M.D.-formulated Relaxium Calm ... Relaxium Calm ’s main ingredient is Sensoril®, an extract of the ashwagandha ...
(Date:12/5/2018)... ... December 05, 2018 , ... Body ... first plastic surgery practices in Houston to offer the BodyTitePRO treatment. Dr. ... an innovative range of surgical and noninvasive techniques to improve the face, breast ...
(Date:12/5/2018)... ... 05, 2018 , ... Advanced Clinical, a clinical research ... office location in Paris, France during the Partnerships in Clinical Trials Europe conference. ... and additional in-country personnel. , “The new office broadens our CRO and FSP ...
Breaking Medicine News(10 mins):